These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25934289)
41. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Hasegawa Y; Matsubara A; Teishima J; Seki M; Mita K; Usui T; Oue N; Yasui W Cancer Sci; 2007 Jan; 98(1):32-6. PubMed ID: 17052263 [TBL] [Abstract][Full Text] [Related]
42. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins. Xu S; Zhong C; Zhang T; Ding J J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641 [TBL] [Abstract][Full Text] [Related]
43. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor. Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889 [TBL] [Abstract][Full Text] [Related]
44. Enhanced expression of the sis and c-myc oncogenes in human meningiomas. Kazumoto K; Tamura M; Hoshino H; Yuasa Y J Neurosurg; 1990 May; 72(5):786-91. PubMed ID: 2182793 [TBL] [Abstract][Full Text] [Related]
46. A role for matrix remodelling proteins in invasive and malignant meningiomas. Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599 [TBL] [Abstract][Full Text] [Related]
47. Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation. Di Zazzo E; Rienzo M; Casamassimi A; De Rosa C; Medici N; Gazzerro P; Bifulco M; Abbondanza C J Transl Med; 2023 Mar; 21(1):217. PubMed ID: 36964555 [TBL] [Abstract][Full Text] [Related]
49. Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition. Gupta V; Samuleson CG; Su S; Chen TC Neurosurg Focus; 2007; 23(4):E9. PubMed ID: 17961046 [TBL] [Abstract][Full Text] [Related]
50. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Chadwick RB; Jiang GL; Bennington GA; Yuan B; Johnson CK; Stevens MW; Niemann TH; Peltomaki P; Huang S; de la Chapelle A Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2662-7. PubMed ID: 10688904 [TBL] [Abstract][Full Text] [Related]
51. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Schuldiner O; Benvenisty N Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483 [TBL] [Abstract][Full Text] [Related]
52. A hypoxia-inducible factor (HIF)-3α splicing variant, HIF-3α4 impairs angiogenesis in hypervascular malignant meningiomas with epigenetically silenced HIF-3α4. Ando H; Natsume A; Iwami K; Ohka F; Kuchimaru T; Kizaka-Kondoh S; Ito K; Saito K; Sugita S; Hoshino T; Wakabayashi T Biochem Biophys Res Commun; 2013 Mar; 433(1):139-44. PubMed ID: 23485455 [TBL] [Abstract][Full Text] [Related]
53. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878 [TBL] [Abstract][Full Text] [Related]
54. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408 [TBL] [Abstract][Full Text] [Related]
55. Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia. Sasaki O; Meguro K; Tohmiya Y; Funato T; Shibahara S; Sasaki T Br J Haematol; 2002 Dec; 119(4):940-8. PubMed ID: 12472571 [TBL] [Abstract][Full Text] [Related]
56. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Elliott K; Ge K; Du W; Prendergast GC Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017 [TBL] [Abstract][Full Text] [Related]
57. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma. Cai L; Ma X; Huang Y; Zou Y; Chen X Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085 [TBL] [Abstract][Full Text] [Related]
58. Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma. Abbondanza C; de Nigris F; De Rosa C; Rossiello R; Puca GA; Napoli C Oncol Res; 2008; 17(1):33-41. PubMed ID: 18488713 [TBL] [Abstract][Full Text] [Related]
59. Tumor suppressor RIZ1 in obesity and the PI3K/AKT/mTOR pathway. Xie X; Man X; Zhu Z; Yuan D; Huang S Obesity (Silver Spring); 2016 Feb; 24(2):389-97. PubMed ID: 26709097 [TBL] [Abstract][Full Text] [Related]
60. TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity. Zhong J; Kang J; Wang X; Jiang W; Liao H; Yuan J Med Oncol; 2015 Apr; 32(4):118. PubMed ID: 25782870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]